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Background: Noninvasive mechanical ventilation is being used up to continuously by patients
with Duchenne muscular dystrophy (DMD). Invasive and noninvasive tests are used to assess
ventilatory function but there are few reports relating them to extent of ventilator depen-
dence for which simple and cost effective parameters are needed.
Objective: To investigate the relative efficacy of noninvasive lung function parameters for
determining extent of need for ventilator use.
Materials and methods: 83 DMD patients were divided into three groups: no ventilator use
(asymptomatic) (nZ 26) [Group 1], nocturnal ventilator use (symptomatic) (nZ 20) [Group 2],
and full-time ventilator dependence (nZ 37) [Group 3]. Tidal volume (TV), vital capacity (VC),
respiratory rate (RR), inspiratory time (Ti), respiratory cycle time (Ttot), rapid shallow breathing
index (RSBI [RR/TV]), breathing intolerance index (BITI), ventilator requirement index (VRI) and
a new parameter RR/VC were monitored and compared. Data were analyzed with receiver-oper-
ating-characteristic curves (ROC) and the area under the curve (AUC) was calculated.
Results: In group2and3, patientsusedNIV for 3.3 2.1and11.2 4.7 years, respectively. ByROC
comparison, RR/VC (RR/VC 0.024 [AUC,0.921] and0.071 [AUC, 0.935]), RR/TV (RR/TV 0.024riance; AUC, The area under the curve; BITI, Breathing intolerance index; DMD, Duchenne muscular
ers; NIV, Noninvasive ventilation; PEmax, Maximal expiratory pressures; PImax, Maximal inspiratory
, Receiver-operating-characteristic; RR, Respiratory rate; RSBI, Rapid shallow and breathing index;
time; TTMUS, The tensionetime index of the inspiratory muscles; Ttot, Respiratory cycle time; TV,
Ventilator requirement index.
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626 S. Hamada et al.[AUC, 0.905] and 0.153 [AUC, 0.905]), and VC (VC  770 ml [AUC, 0.896] and 370 ml [AUC,
0.898]) represented to introduce nocturnal and continuous ventilator use, respectively. TV/VC,
BITI, and VRI were either less sensitive or less specific.
Conclusions: Lung function parameters including RR/VC, RR/TV, and VC are useful and inexpen-
sive in predicting the extent of need for ventilator use. Overall, RR/VC is the most appropriate
predictor for determining extent of need for ventilator use.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Duchenne muscular dystrophy (DMD) is an X-linked progres-
sive neuromuscular disease due to the absence of dystro-
phin in the subsarcolemmal cytoskeleton that occurs in
about 1 in 3600e6000 males.1 Respiratory muscle weakness
is progressive and results in symptomatic sleep hypo-
ventilation usually in the late teens. Respiratory complica-
tions, including lower tract infections, atelectasis, and
retained secretions are the main causes of morbidity and
mortality. FVC of <1L is a predictor of poor outcome, with
a 5-year survival rate of only 8% if assisted ventilation is not
provided.33 Without ventilator support, the life expectancy
inDMDhas been reported to beabout 19 years2 butwith it can
exceed 4 decades.3e6 Besides managing acute and chronic
ventilatory failure, it is useful in cardioprotection by pre-
venting cor pulmonale.7 Despite therapeutic advances in
assisting inspiratory and expiratory muscle function to
prolong survival,3,8 there is no general consensus on what
parameters should indicate initiation and extent of venti-
lator use.9,10 In 2004, the American Thoracic Society rec-
ommended nocturnal polysomnography (PSG) and/or pulse
oximetry with carbon dioxide monitoring to indicate intro-
duction of noninvasive ventilation (NIV) for DMD.11 However,
PSG is not universally available, is time consuming, expen-
sive, and not available during routine evaluations when
decisions about NIV need to be made,12 and PSG is pro-
grammed to attribute apneas and hypopneas only to central
and obstructive events rather than to inspiratory muscle
dysfunction. In addition, appreciation of symptoms of inspi-
ratorymuscle dysfunction is often delayed in DMDpatients.13
Thus, prescription of ventilatory assistance can be delayed
despite severe lung dysfunction.
Despite therapeutic advances for DMD, there has been no
significant change over the past 20 years in the time from
symptom onset to diagnosis.9,10 In addition, the frequency
and circumstances of childhood mortality are geographically
and socio-economically dependent14 and the main causes
of mortality are from complications of respiratory muscle
weakness. Therefore, basic and low cost indicators for insti-
tution of NIV are needed. Baydur A et al30 and a consensus
conference32 reported that it is considered to require NIV
when VC decreased to 500e700 ml and below 50% predicted,
respectively. Hahn et al. reported that noninvasive determi-
nation of the tensionetime index of the inspiratory muscles
(TTMUS) can help to justify the extent of need for NIV.
15
Fauroux et al. studied the correlation between several voli-
tional and non-volitional parameters and the need for NIV.16
We proposed a breathing intolerance index (BITI)17 and
ventilator requirement index (VRI)18 as noninvasive indica-
tors. BITI was defined as multiplying Ti/Ttot by TV/VC, while
VRIwasobtainedbymultiplyingBITI byRR.But these require adigital spirometer with specific software. We now consider
RR/VC. The purpose of this study was to investigate the
relative efficacy of these noninvasive lung function parame-
ters for determining extent of need for ventilator use.
Materials and methods
A retrospective analysis was undertaken of 83 DMD patients
followed up at National Yakumo Hospital since 2003 with
diagnosis establishedbydystrophin absenceonmusclebiopsy
or by DNA analysis. All patients were wheelchair-bound by
age 12. We introduced nocturnal NIV when patients had
symptoms of nocturnal hypoventilation including increasing
nocturnal awakenings, daytime sleepiness, morning head-
aches, and palpitations. Patients extended use to around-
the-clock and were provided with a simple 15 mm angled
mouth piece for daytime use when dyspnea developed upon
cessation of NIV in the morning and as a result of daytime
hypercapnia. The patients were divided into three cate-
gories: Group 1 patients were asymptomatic and not using
ventilators; Group 2 patients used nocturnal NIV for relief
of symptoms; and Group 3 required both nocturnal and
daytime ventilator use. A Meteor digital spirometer with
a liquid crystal diode monitor (Cardio-Pulmonary technolo-
gies, Sussex, WI) was used with custom-prepared software
for a Windows-based personal computer (FMV-660 MC/W, A
Fujitsu Corporation, Tokyo, Japan). The computer selected
the six most consistent tidal TV waveforms with the patient
supine and at rest and it averaged them for the Ti, Ttot, and
TV data. With this equipment, TV, VC, RR, inspiratory time
(Ti), and respiratory cycle time (Ttot) were analyzed. Then,
RSBI [RR/TV], BITI, and VRI were analyzed along with RR/VC.
We calculated RR/VC by multiplying TV/VC by RR/TV. All
measurements were performed with the patients at supine
since some patients could not sit. Absolute VC values were
used because comparing percentage of predicted normal is
not meaningful when lung volumes are very small and these
are difficulties in translating absolute volumes to percentage
of predicted for patients with severe back deformity.19 One
technician performed all measurements. Arterial blood gas
analysis was not done because 30% of people hyperventilated
because of the pain of the arterial puncture, temporarily
decreasing carbon dioxide tensions.34
Statistical analysis
Data were analyzed by one-way analysis of variance
(ANOVA). For all post-ANOVA intergroup comparisons, we
used Tukey-Kramer test. Sensitivity and specificity were
calculated, and the data were also analyzed with receiver-
operating-characteristic (ROC) curves, in which the propor-
tions of true positive results and false positive results were
Table 1 Spirometer analysis data. Data are presented as mean  standard deviation (SD).
Group 1 Group 2 Group 3 ANOVA, p value
Patients, No. 26 20 37
Age, yra 17.8  5.0 22.3  4.9 30.2  5.8 <0.05b,c,d
RR, breaths/mina 16.81  5.25 21.8  5.58 30.57  7.66 <0.05b,c,d
VC, mla 1330  540 630  280 280  150 <0.05b,c,d
TV, mla 325  118 234  74.0 144  62.7 <0.05b,c,d
RR/TV, breaths/mla 0.057  0.023 0.102  0.041 0.253  0.128 <0.05c,d
BITIa 0.117  0.042 0.196  0.069 0.257  0.080 <0.05b,c,d
VRIa 1.97  1.04 4.31  1.89 7.90  3.37 <0.05b,c,d
RR/VC, breaths/mla 0.0149  0.008 0.041  0.022 0.149  0.097 <0.05c,d
a ANOVA significance (p < 0.05).
b Tukey-Kramer test significance, group 1 vs 2.
c Tukey-Kramer test significance, group 2 vs 3.
d Tukey-Kramer test significance, group 1 vs 3.
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under the curve (AUC) to reflect the accuracy of the index.
Threshold cut-off values were calculated by providing the
best compromise between the optimal sensitivity and
specificity.
Results
Eighty-three patients were included in the study. Twenty-
six patients were not ventilated (Group 1). Twenty pati-
ents were treated with nocturnal NIV, and used essentially
nocturnal-only NIV for 3.3  2.1 years (Group 2). Thirty-
seven patients extended use to around-the-clock, and used
NIV for 11.2  4.7 years (Group 3).
Demographic data and pulmonary data are in Table 1.
Alongwith ventilator dependency, RRprogressively increased
(p < 0.05). VC and TV progressively decreased for all three
groups.
Table 2 illustrates the cut-off values to introduce
nocturnal ventilator use. VC, RR/TV, and RR/VC had AUCs of
0.896, 0.905, and 0.921, respectively, indicating good diag-
nostic accuracy. Cut-offs of VC 770ml, RR/TV 0.024, and
RR/VC  0.024 had sensitivities of 85%, 81%, and 85%,
respectively, and specificities of 89%, 90%, and 89%, respec-
tively. Table 3 shows the cut-off values to introduce contin-
uous ventilator use. VC, RR/TV, and RR/VC had AUCs of
0.898, 0.905, and 0.935, respectively, indicating good diag-
nostic accuracy. Cut-offs of VC 370ml, RR/TV 0.153, and
RR/VC  0.071 had sensitivities of 78%, 81%, and 86%,
respectively, and specificities of 85%, 90%, and 95%, respec-
tively. Fig. 1 illustrates ROC curves of RR/VC values thatTable 2 Pulmonary function parameter sensitivity and specifici
the curve (AUC): 1 Z perfect discrimination between Group 1 an
Parameters Cut-off AUC
VC, ml 770 0.896
TV/VC 0.3 0.806
RR/TV, breaths/ml 0.024 0.905
BITI 0.144 0.835
VRI 3.04 0.863
RR/VC, breaths/ml 0.024 0.921indicate nocturnal (Fig. 1A) and continuous ventilator use
(Fig. 1B) with AUC 0.921, and 0.935, respectively.
Discussion
Lung volumes are used to gauge the severity of respiratory
muscle impairment in DMD.20 It is recommended that VC,
peak cough flow, and maximal inspiratory (PImax) and
expiratory pressures (PEmax) should have to be routinely
evaluated.2,11 But, in patients with facial muscle weakness
or general bulbar-innervated muscle dysfunction, technical
difficulties and leak problems may limit PImax and PEmax
accuracy.21,22 Furthermore, low values of these parameters
can also be difficult to interpret.23 Sniff nasal inspiratory
pressure correlates with inspiratory muscle strength, is easy
to perform, and noninvasive and is generated during
a ballistic maneuver.22,24 However, tachypneic DMD patients
may not be able to performa rapid sniffmaneuver.25 Invasive
parameters including sniff esophageal pressure, sniff trans-
diaphragmatic pressure, twitch transdiaphragmatic pres-
sure, twitch T10 gastric pressure,23 and cough gastric
pressure22 have been used. However, because of their inva-
sive nature these tests cannot be routinely performed.
Although Nicot et al. reported that these invasive tests were
easier to perform for neuromuscular disorders,20 they
analyzed only young and relatively strong patients. Never-
theless, neither the invasive nor the noninvasive parameters
mentioned above are quantitative indicators for extent of
need for ventilatory assistance.
There are three reports relating lung function parameters
to NIV dependence.15,16,18 Fauroux et al. correlated severalty for DMD part-time ventilator use requirement. Area under
d 2; 0.5 Z poor discrimination with 50% chance of error.
Sensitivity, % Specificity, %
85 89
80 73
81 90
75 85
70 89
85 89
Table 3 Pulmonary function parameter sensitivity and specificity for DMD full-time ventilator use requirement. Area under
the curve (AUC): 1 Z perfect discrimination between Group 2 and 3; 0.5 Z poor discrimination with 50% chance of error.
Parameters Cut-off AUC Sensitivity, % Specificity, %
VC, ml 370 0.898 78 85
TV/VC 0.48 0.789 70 80
RR/TV, breaths/ml 0.153 0.905 81 90
BITI 0.246 0.717 59 85
VRI 6.96 0.825 62 90
RR/VC, breaths/ml 0.071 0.935 86 95
628 S. Hamada et al.volitional and non-volitional parameters with need for NIV16
but noted only that the test results were lower in children
using NIV. Hahn et al. reported that noninvasive determina-
tion of the tensionetime index of the inspiratory muscles
(TTMUS) might help to justify the extent of need for NIV.
15
TTMUS surpassed 0.23 and 0.37 in 95% of subjects ventilated
8e20 h per day and >20 h per day, respectively. Bach et al.
reported that a VC < 50% or a VRI> 1.2 had a 95% sensitivity
for the justification of a ventilator for nocturnal use, while
a VC < 1100 ml or VRI > 2.5 was 93% sensitive for predicting
need for a second ventilator but ROC curves were not
analyzed.18 VRI is calculated by multiplying BITI by RR and
BITI by multiplying Ti/Ttot by TV/VC. In reevaluating our
earlier BITI and VRI data, Ti/Ttot did not vary significantly
with the extent of ventilator need.17,18 Therefore, it does
not seem to be necessary to include Ti/Ttot measurements
(that require a specific spirometer) to evaluate this.
This study investigated the relative sensitivity and
specificity of noninvasive lung function parameters for
determining extent of need for ventilator use and found
that the RR/VC and VC were the most sensitive and specific
parameters. RR/VC was most sensitive and specific for
indicating the need to initiate full-time NIV. RR/TV and
TV/VC have been reported to correlate with dyspnea.26
RR/TV reflects rapid shallow breathing, is a ventilator
weaning predictor.27 Furthermore, high value of RR/TV can
cause hypercapnia.28 Interestingly, Toussaint et al. stated
that TV/VC > 0.33 accurately predicted daytime hyper-
capnia (ROC, 0.923) but RR/TV could not (ROC, 0.604).12Figure 1 The ROC curves of RR/VC for indicating need for ventil
AUC 0.921, Fig. B AUC 0.935.VC decreases at 200e250 ml (5e10%) per year following
plateau between ages 9 and 16 before the rate of decrease
tapers off below 400 ml.31 VC measurements have become
popular for assessing respiratory muscle weakness and to
predict respiratory failure in neuromuscular disease.12,29 It
was reported that nocturnal and full-time NIV were required
when VC was 500e700 ml and about 300 ml, respectively.30
Toussaint et al. suggested that DMD patients were at high
risk for diurnal hypercapnia when VC decreased below
680 ml. Hahn et al. also suggested that VC was sensitive in
recognizing subjects who need NIV. Our results suggest that
VC  770 and 370 ml are predictive for nocturnal and full-
time ventilator use, respectively. In addition, RR/VCwas the
most appropriate screening parameter because it yielded
the lowest proportion of false negative results. VC can be
analyzedwith a simple, portable spirometer. RR is also easily
obtained. In predicting full-time NIV need, VC alone yielded
a relatively high false negative rate because patients’ NIV
dependence varies greatly once VC decreases below 400 ml.
Therefore, we suggest that RR/VC is the simplest and most
accurate parameter for indicating extent of need for long-
term ventilator use.
Limitations of this study include its retrospective nature
and the small numbers of subjects. We also did not correlate
lung function and overnight and/or awake CO2 measure-
ment. Prospective studies are warranted.
We conclude that RR/VC  0.024 and 0.071, respec-
tively, are most useful screening parameters to justify the
need for sleep NIV and continuous NIV. RR/VC, thereby, canator use (Fig. 1A) and full-time ventilator use (Fig. 1B). Fig. A:
Indicators for ventilator use in Duchenne muscular dystrophy 629best justify the need for a second ventilator for daytime
use and as a back-up for NIV dependent patients.
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